Glucose clamp technique: a method for quantifying insulin secretion and resistance RA DeFronzo, JD Tobin, R Andres American Journal of Physiology-Gastrointestinal and Liver Physiology 237 (3 …, 1979 | 10001 | 1979 |
Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease RA DeFronzo, E Ferrannini Diabetes care 14 (3), 173-194, 1991 | 7041 | 1991 |
Report of the expert committee on the diagnosis and classification of diabetes mellitus Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes care 21 (Supplement_1), S5-S19, 1998 | 6500* | 1998 |
Report of the expert committee on the diagnosis and classification of diabetes mellitus JR Gavin III, K Alberti, MB Davidson, RA DeFronzo Diabetes Care 24, S5, 2001 | 6418* | 2001 |
Report of the expert committee on the diagnosis and classification of diabetes mellitus JR Gavin III, K Alberti, MB Davidson, RA DeFronzo Diabetes care 20 (7), 1183, 1997 | 6418* | 1997 |
Report of the expert committee on the diagnosis and classification of diabetes mellitus JR Gavin, K Alberti, MB Davidson, RA DeFronzo, A Drash, SG Gabbe, ... Diabetes Care 23, S4-S19, 2000 | 6417* | 2000 |
Insulin sensitivity indices obtained from oral glucose tolerance test: Comparison with the euglycemic insulin clamp M Matsuda, RA Defronzo Diabetes 48, A79-A79, 1999 | 6319 | 1999 |
Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. M Matsuda, RA DeFronzo Diabetes care 22 (9), 1462-1470, 1999 | 6317 | 1999 |
From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus RA DeFronzo Diabetes 58 (4), 773-795, 2009 | 3864 | 2009 |
The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM RA DeFronzo Diabetes 37 (6), 667-687, 1988 | 3761 | 1988 |
International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes DM Nathan, DM Nathan, B Balkau, E Bonora, K Borch-Johnsen, JB Buse, ... Diabetes Care 32 (7), 1327-1334, 2009 | 3536 | 2009 |
Pathogenesis of NIDDM: a balanced overview RA DeFronzo, RC Bonadonna, E Ferrannini Diabetes care 15 (3), 318-368, 1992 | 3097 | 1992 |
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1 ME Patti, AJ Butte, S Crunkhorn, K Cusi, R Berria, S Kashyap, Y Miyazaki, ... Proceedings of the National Academy of Sciences 100 (14), 8466-8471, 2003 | 2416 | 2003 |
The effect of insulin on the disposal of intravenous glucose: results from indirect calorimetry and hepatic and femoral venous catheterization RA DeFronzo, E Jacot, E Jequier, E Maeder, J Wahren, JP Felber Diabetes 30 (12), 1000-1007, 1981 | 2267 | 1981 |
Skeletal muscle insulin resistance is the primary defect in type 2 diabetes RA DeFronzo, D Tripathy Diabetes care 32 (suppl 2), S157-S163, 2009 | 2255 | 2009 |
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis R Belfort, SA Harrison, K Brown, C Darland, J Finch, J Hardies, B Balas, ... New England Journal of Medicine 355 (22), 2297-2307, 2006 | 2206 | 2006 |
Impaired fasting glucose and impaired glucose tolerance implications for care DM Nathan, MB Davidson, RA Defronzo, RJ Heine, RR Henry, R Pratley, ... Diabetes care 30 (3), 753-759, 2007 | 2117 | 2007 |
Consensus Statement Impaired fasting glucose and impaired glucose tolerance: implications for care DM Nathan, M Davidson, RA DeFronzo, RJ Heine, RR Henry, R Pratley, ... DIABETES CARE-ALEXANDRIA VA- 30 (3), 753, 2007 | 2117* | 2007 |
Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes RA DeFronzo, RE Ratner, J Han, DD Kim, MS Fineman, AD Baron Diabetes care 28 (5), 1092-1100, 2005 | 2092 | 2005 |
Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes RA DeFronzo, RE Ratner, J Han, DD Kim, MS Fineman, AD Baron Diabetes care 28 (5), 1092-1100, 2005 | 2088 | 2005 |